Physician profile
Vipul Dua
NPI 1730103862
$7,033.86
in general payments reported to CMS, 2019-2025
19 companies · $1,229 in 2025
The $1,229 reported for 2025 was more than what a typical Orthopaedic Surgery provider received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $476 · 2020: $273 · 2021: $455 · 2022: $3,145 · 2023: $1,199 · 2024: $257 · 2025: $1,229.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $2,030 · Food and Beverage: $655.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $2,030.25 |
| Food and Beverage | $654.55 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $5,222.72 | 2021-2025 | Mako |
| Depuy Synthes Sales INC. | $418.95 | 2019-2025 | Orthovisc, Monovisc |
| Pfizer INC. | $189.65 | 2019-2021 | |
| Smith+Nephew, INC. | $173.64 | 2019-2022 | |
| Bioventus LLC | $171.30 | 2019-2023 | Gelsyn-3, Durolane |
| Zimmer Biomet Holdings, INC. | $170.07 | 2021-2022 | |
| Pacira Therapeutics, INC. | $158.21 | 2019-2021 | |
| Medtronic, INC. | $123.74 | 2022 | |
| Intellijoint Surgical INC. | $91.34 | 2019 | |
| Vertex Pharmaceuticals Incorporated | $77.79 | 2025 | |
| Medacta USA, INC. | $59.00 | 2023 | Gmk Sphere |
| Davol INC. | $48.27 | 2024 | Arista Ah Flexitip |
| Horizon Therapeutics Plc | $27.05 | 2022 | |
| Kci USA, INC. | $23.02 | 2020 | |
| Djo, LLC | $22.07 | 2019 |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ferring Pharmaceuticals INC. | $17.57 | 2024 | Euflexxa |
| Fidia Pharma USA INC. | $14.18 | 2019 | |
| Janssen Pharmaceuticals, INC | $13.59 | 2019 | |
| Sanofi-Aventis U.S. LLC | $11.70 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Vipul Dua listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.